Copyright
©The Author(s) 2021.
World J Crit Care Med. Jan 9, 2021; 10(1): 12-21
Published online Jan 9, 2021. doi: 10.5492/wjccm.v10.i1.12
Published online Jan 9, 2021. doi: 10.5492/wjccm.v10.i1.12
Variable | Group I (LMS), 75 (%) | Group II (no LMS), 324 (%) | P value |
Inotrops | |||
Dopamine, mean dose (μg/kg/min), mean ± SD | 9 (12), 6.50 ± 3.10 | 31 (9.6), 7.23 ± 15.2 | 0.5, 0.34 |
Adrenaline, mean dose (μg/kg/min), mean ± SD | 6 (8), 0.06 ± 0.01 | 27 (8.3), 0.05 ± 0.009 | 0.6, 0.8 |
Noradrenline, mean dose (μg/kg/min), mean ± SD | 12 (16), 0.08 ± 0.01 | 43 (13.2), 0.07 ± 0.008 | 0.4, 0.7 |
Dobutamine, mean dose (μg/kg/min), mean ± SD | 4 (5.3), 4.5 ± 1.4 | 11 (3.3), 3.9 ± 1.1 | 0.06, 0.09 |
Milrinone, mean dose (μg/kg/min), mean ± SD | 3 (4), 0.56 ± 0.05 | 7 (2.1), 0.6 ± 0.04 | 0.9, 0.4 |
Intraoperative parameters | |||
CPB time (min) | 139 ± 43 | 125 ± 69.6 | 0.6 |
ACC time (min) | 87.1 ± 34 | 79.3 ± 30.1 | 0.9 |
Anesthesia time (min) | 6.6 ± 1.4 | 6.5 ± 1.8 | 0.9 |
Grafts | 3.1 ± 0.8 | 3.4 ± 1.01 | 0.7 |
Postoperative parameters | |||
LOV (min) | 384.1 ± 123 | 375.1 ± 119 | 0.8 |
LOSICU (h) | 65.9 ± 46.1 | 63.4 ± 43.9 | 0.6 |
LOShosp (d) | 16.1 ± 4.2 | 14.7 ± 3.7 | 0.6 |
VIS | 6.4 ± 2.6 | 6.1 ± 2.2 | 0.4 |
Post-operative outcome | |||
POAF | 12 (16) | 39 (12) | 0.06 |
AKI | 20 (26.7) | 75 (23.1) | 0.09 |
In-hospital-mortality | 2 (2.7) | 7 (2.1) | 0.8 |
VAP | 1 (1.3) | 5 (1.5) | 0.7 |
VA-ECMO | 2 (2.7) | 4 (1.2) | 0.08 |
Re-admission ICU | 2 (2.7) | 8 (2.5) | 0.8 |
Re-exploration | 6 (8) | 26 (8.6) | 0.5 |
PMI | 3 (4) | 11 (3.3) | 0.4 |
- Citation: Omar AS, Hanoura S, Shouman Y, Sivadasan PC, Sudarsanan S, Osman H, Pattath AR, Singh R, AlKhulaifi A. Intensive care outcome of left main stem disease surgery: A single center three years’ experience. World J Crit Care Med 2021; 10(1): 12-21
- URL: https://www.wjgnet.com/2220-3141/full/v10/i1/12.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v10.i1.12